ctrl K

Cytek Biosciences Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD

3.75

0.05 (1.35%)

At close: May 02, 2025, 10:06 AM

Cytek Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	200.45M	193.01M	164.04M	127.95M	92.84M	57.88M
Cost of Revenue	89.35M	83.59M	63.06M	48.81M	41.13M	29.21M
Gross Profit	111.11M	109.43M	100.97M	79.14M	51.71M	28.67M
Operating Income	-20.52M	-27.84M	-1.83M	6.45M	13.66M	3.73M
Interest Income	5.12M	6.41M	4.62M	49K	110K	711K
Pretax Income	-5.7M	-15.71M	1.26M	5.95M	14.43M	-16.29M
Net Income	-6.02M	-12.15M	2.58M	4.42M	19.41M	-16.83M
Selling & General & Admin	92.23M	91.62M	67.92M	45.53M	24.36M	16.98M
Research & Development	39.4M	44.15M	34.86M	24.44M	13.69M	8.93M
Other Expenses	n/a	n/a	1.02M	-1.53M	994K	252K
Operating Expenses	131.63M	137.27M	102.78M	69.98M	38.05M	25.91M
Interest Expense	5.24M	2.07M	2.57M	1.74M	333K	1K
Selling & Marketing Expenses	49.11M	49.15M	33.23M	24.71M	14.99M	10.24M
Cost & Expenses	220.98M	220.86M	165.84M	118.78M	79.18M	55.12M
Income Tax Expense	320K	-3.56M	-1.22M	1.5M	-4.98M	533K
Shares Outstanding (Basic)	130.61M	135.28M	134.51M	133.75M	132.99M	132.99M
Shares Outstanding (Diluted)	130.61M	135.28M	138.56M	133.75M	132.99M	132.99M
EPS (Basic)	-0.05	-0.09	0.02	0.03	0.02	-0.13
EPS (Diluted)	-0.05	-0.09	0.02	0.03	0.02	-0.13
EBITDA	-10.03M	-4.41M	9.54M	10.4M	15.37M	-15.98M
EBIT	-20.52M	-13.64M	3.83M	9.16M	13.66M	-16.29M
Depreciation & Amortization	10.49M	9.23M	5.7M	1.24M	603K	309K